Roche Holding Stock Forecast for 2023 - 2025 - 2030

Updated on 09/26/2023

Stock Rating
5
Price Target
CHF365.00
Consensus
Outperform
Upside
24.32%
Analysts
9
Stock Rating
5
Upside
24.32%
Analysts
9
Price Target
CHF365.00

Roche Holding Stock Forecast and Price Target

Roche Holding's stock is projected to advance by 24.32% from the previous closing price if it reaches the average target of CHF365.00 by the year's end, as nine reputable analysts recently projected. This potential upside is calculated on a high-end estimate of CHF450.00 and a low-end estimate of CHF265.00. If you're looking for information on Roche Holding stock, consider checking out the forecasts for comparable firms such as NasdaqGS:AMGN.

CHF365.00

24.32% Upside

Outperform
Outperform

Roche Holding Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, Roche Holding's Price has seen a drop from CHF320.95 to CHF315.38 – a 1.74% decrease. According to 0 major analysts, Roche Holding's Fair Value will fall by 0.45% in the next year, reaching CHF313.97. Professionals believe that By 2030, Roche Holding's Fair Value will fall to CHF313.79– a 0.50% decrease from its current value.

2022 Fair Value Forecast
CHF313.97
2023 Fair Value Forecast
CHF316.47
2024 Fair Value Forecast
CHF312.65
2025 Fair Value Forecast
CHF313.57
2026 Fair Value Forecast
CHF313.71
2027 Fair Value Forecast
CHF314.63
2028 Fair Value Forecast
CHF313.97
2029 Fair Value Forecast
CHF313.84
2030 Fair Value Forecast
CHF313.79
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly & Co Outperform 14
$552.32 Buy/Sell $333.19 -27.58%
AVGO Stock Forecast Broadcom Inc Outperform 7
$833.89 Buy/Sell $656.43 -20.97%
ABBV Stock Forecast AbbVie Outperform 10
$154.72 Buy/Sell $162.24 6.64%
AZN Stock Forecast AstraZeneca PLC Buy 8
£11.14k Buy/Sell £153.20 -98.60%
ABT Stock Forecast Abbott Laboratories Outperform 10
$97.47 Buy/Sell $124.05 28.24%

Roche Holding Revenue Forecast for 2023 - 2025 - 2030

Roche Holding's Revenue has increased by 3.29% In the last two years, going from CHF63.75B to CHF65.85B. According to 0 major analysts, Roche Holding's Revenue will fall by 3.69% in the next year, reaching CHF63.42B. Professionals believe that By 2030, Roche Holding's Revenue will fall to CHF63.48B– a 3.60% decrease from its current value.

2022 Rev Forecast
CHF63.42B
2023 Rev Forecast
CHF63.66B
2024 Rev Forecast
CHF62.62B
2025 Rev Forecast
CHF63.69B
2026 Rev Forecast
CHF63.60B
2027 Rev Forecast
CHF63.63B
2028 Rev Forecast
CHF63.29B
2029 Rev Forecast
CHF63.42B
2030 Rev Forecast
CHF63.48B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DHR Stock Forecast Danaher Corp Outperform 10
$252.04 Buy/Sell $304.24 20.81%
AMGN Stock Forecast Amgen Inc Hold 7
$266.86 Buy/Sell $268.00 4.17%
GE Stock Forecast General Electric Outperform 7
$111.71 Buy/Sell $127.45 -22.12%

Roche Holding Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Roche Holding's Dividend per Share has grown, increasing from CHF9.00 to CHF9.30 – a growth of 3.33%. In the next year, 0 analysts estimate that Roche Holding's Dividend per Share will decrease by 1.80%, reaching CHF9.13. According to professional forecasts, in 2030, Roche Holding's Dividend per Share will decrease by 1.72%, reaching CHF9.14.

2022 DPS Forecast
CHF9.13
2023 DPS Forecast
CHF9.09
2024 DPS Forecast
CHF9.09
2025 DPS Forecast
CHF9.16
2026 DPS Forecast
CHF9.15
2027 DPS Forecast
CHF9.13
2028 DPS Forecast
CHF9.12
2029 DPS Forecast
CHF9.13
2030 DPS Forecast
CHF9.14
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BSX Stock Forecast Boston Scientific Corp Outperform 15
$53.81 Buy/Sell $52.51 -7.08%
BDX Stock Forecast Becton, Dickinson and Outperform 17
$266.77 Buy/Sell $300.43 3.09%
GSK Stock Forecast GSK Outperform 16
£1.53k Buy/Sell £16.95 -98.95%

Roche Holding Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last two years, Roche Holding's Free Cash Flow has decreased from CHF18.88B to CHF17.45B – a 7.59% drop. In the following year, 0 experts forecast that Roche Holding's Free Cash Flow will decrease by 0.69%, to CHF17.33B. In 2030, professionals predict that Roche Holding's Free Cash Flow will decrease by 1.00%, to CHF17.27B.

2022 FCF Forecast
CHF17.33B
2023 FCF Forecast
CHF18.05B
2024 FCF Forecast
CHF17.02B
2025 FCF Forecast
CHF17.17B
2026 FCF Forecast
CHF17.24B
2027 FCF Forecast
CHF17.51B
2028 FCF Forecast
CHF17.35B
2029 FCF Forecast
CHF17.29B
2030 FCF Forecast
CHF17.27B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MMM Stock Forecast 3M Co Hold 16
$94.79 Buy/Sell $147.79 26.07%
BAYN Stock Forecast Bayer Outperform 7
46.32€ Buy/Sell 74.54€ 63.00%
4568 Stock Forecast Daiichi Sankyo Company Outperform 18
¥4.07k Buy/Sell ¥0.00 35.30%

Roche Holding Net Income Forecast for 2023 - 2025 - 2030

In the last two years, Roche Holding's Net Income has grown by 3.21%, from CHF13.50B to CHF13.93B. According to 0 analysts, Roche Holding's Net Income will fall by 0.11% in the next year, reaching CHF13.91B. Professionals believe that By 2030, Roche Holding's Net Income will fall to CHF13.92B – a 0.04% decrease from its current value.

2022 NI Forecast
CHF13.91B
2023 NI Forecast
CHF13.78B
2024 NI Forecast
CHF13.95B
2025 NI Forecast
CHF13.94B
2026 NI Forecast
CHF13.93B
2027 NI Forecast
CHF13.88B
2028 NI Forecast
CHF13.91B
2029 NI Forecast
CHF13.92B
2030 NI Forecast
CHF13.92B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DXCM Stock Forecast DexCom Inc Buy 16
$86.06 Buy/Sell $129.69 45.83%
CTVA Stock Forecast Corteva Inc Outperform 12
$51.27 Buy/Sell $73.12 42.38%
6501 Stock Forecast Hitachi Buy 18
¥6.56k Buy/Sell ¥0.00 29.65%

Roche Holding EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Roche Holding's EBITDA has decreased by 2.83%, going from CHF24.97B to CHF24.27B. For next year, analysts predict EBITDA of CHF24.39B, which would mean an increase of 0.49%. Over the next nine years, experts predict that Roche Holding's EBITDA will grow at a rate of 0.41%.

2022 EBITDA Forecast
CHF24.39B
2023 EBITDA Forecast
CHF24.59B
2024 EBITDA Forecast
CHF24.36B
2025 EBITDA Forecast
CHF24.33B
2026 EBITDA Forecast
CHF24.35B
2027 EBITDA Forecast
CHF24.43B
2028 EBITDA Forecast
CHF24.40B
2029 EBITDA Forecast
CHF24.38B
2030 EBITDA Forecast
CHF24.37B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
A Stock Forecast Agilent Technologies Outperform 17
$111.94 Buy/Sell $141.56 48.74%
4519 Stock Forecast Chugai Pharmaceutical Hold 18
¥3.31k Buy/Sell ¥0.00 36.03%
ALC Stock Forecast Alcon Outperform 15
CHF66.18 Buy/Sell CHF0.00 30.51%

Roche Holding EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Roche Holding's EBIT has decreased from CHF21.03B to CHF20.19B – a 4.02% drop. For next year, analysts predict EBIT of CHF20.32B, which would mean an increase of 0.64%. Over the next nine years, experts predict that Roche Holding's EBIT will grow at a rate of 0.54%.

2022 EBIT Forecast
CHF20.32B
2023 EBIT Forecast
CHF20.57B
2024 EBIT Forecast
CHF20.27B
2025 EBIT Forecast
CHF20.25B
2026 EBIT Forecast
CHF20.27B
2027 EBIT Forecast
CHF20.37B
2028 EBIT Forecast
CHF20.34B
2029 EBIT Forecast
CHF20.31B
2030 EBIT Forecast
CHF20.30B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DD Stock Forecast DuPont de Nemours Inc Outperform 17
$73.36 Buy/Sell $80.32 9.05%
ILMN Stock Forecast Illumina Inc Outperform 16
$131.41 Buy/Sell $254.08 89.86%
GMAB Stock Forecast Genmab A/S Outperform 16
kr3.00k Buy/Sell kr2.84k -8.24%

Roche Holding EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, Roche Holding's EPS has seen a drop from CHF20.16 to CHF19.81 – a 1.74% decrease. According to 0 major analysts, Roche Holding's EPS will fall by 0.45% in the next year, reaching CHF19.72. Professionals believe that By 2030, Roche Holding's EPS will fall to CHF19.71– a 0.50% decrease from its current value.

2022 EPS Forecast
CHF19.72
2023 EPS Forecast
CHF19.88
2024 EPS Forecast
CHF19.64
2025 EPS Forecast
CHF19.70
2026 EPS Forecast
CHF19.71
2027 EPS Forecast
CHF19.76
2028 EPS Forecast
CHF19.72
2029 EPS Forecast
CHF19.71
2030 EPS Forecast
CHF19.71
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PODD Stock Forecast Insulet Corp Outperform 15
$154.67 Buy/Sell $302.13 106.89%
4523 Stock Forecast Eisai Hold 18
¥8.15k Buy/Sell ¥0.00 -18.99%
HOLX Stock Forecast Hologic Inc Outperform 8
$84.06 Buy/Sell $79.86 -1.86%